These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 30245511)

  • 1. A new clinical screening strategy and prevalence estimation for glucokinase variant-induced diabetes in an adult Chinese population.
    Ma Y; Han X; Zhou X; Li Y; Gong S; Zhang S; Cai X; Zhou L; Luo Y; Li M; Liu W; Zhang X; Ren Q; Ji L
    Genet Med; 2019 Apr; 21(4):939-947. PubMed ID: 30245511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY) Patients.
    Wędrychowicz A; Tobór E; Wilk M; Ziółkowska-Ledwith E; Rams A; Wzorek K; Sabal B; Stelmach M; Starzyk JB
    J Clin Res Pediatr Endocrinol; 2017 Sep; 9(3):246-252. PubMed ID: 28663157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucokinase Deficit Prevalence in Women With Diabetes in Pregnancy: A Matter of Screening Selection.
    Bitterman O; Giuliani C; Festa C; Napoli A
    Front Endocrinol (Lausanne); 2020; 11():268. PubMed ID: 32508747
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic and clinical characteristics of Chinese children with Glucokinase-maturity-onset diabetes of the young (GCK-MODY).
    Li X; Ting TH; Sheng H; Liang CL; Shao Y; Jiang M; Xu A; Lin Y; Liu L
    BMC Pediatr; 2018 Mar; 18(1):101. PubMed ID: 29510678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 0.1% of the population with glucokinase monogenic diabetes can be recognized by clinical characteristics in pregnancy: the Atlantic Diabetes in Pregnancy cohort.
    Chakera AJ; Spyer G; Vincent N; Ellard S; Hattersley AT; Dunne FP
    Diabetes Care; 2014; 37(5):1230-6. PubMed ID: 24550216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Type 2 diabetes on Glucokinase diabetes (GCK-MODY) phenotype in a Roma (Gypsy) family - case report.
    Stanik J; Kusekova M; Huckova M; Valentinova L; Masindova I; Stanikova D; Ferenczova J; Gasperikova D; Klimes I
    Endocr Regul; 2012 Apr; 46(2):99-105. PubMed ID: 22540858
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Childhood-onset mild diabetes caused by a homozygous novel variant in the glucokinase gene.
    Filibeli BE; Çatli G; Ayranci İ; Manyas H; Kirbiyik Ö; Dündar B
    Hormones (Athens); 2022 Mar; 21(1):163-169. PubMed ID: 34697762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lower Circulating miR-122 Level in Patients with HNF1A Variant-Induced Diabetes Compared with Type 2 Diabetes.
    Huang X; Gong S; Ma Y; Cai X; Zhou L; Luo Y; Li M; Liu W; Zhang S; Zhang X; Ren Q; Zhu Y; Zhou X; Zhang R; Chen L; Gao X; Zhang F; Wang Y; Han X; Ji L
    J Diabetes Res; 2018; 2018():7842064. PubMed ID: 30155490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition and Management of Individuals With Hyperglycemia Because of a Heterozygous Glucokinase Mutation.
    Chakera AJ; Steele AM; Gloyn AL; Shepherd MH; Shields B; Ellard S; Hattersley AT
    Diabetes Care; 2015 Jul; 38(7):1383-92. PubMed ID: 26106223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caudal regression syndrome in a fetus of a glucokinase-maturity-onset diabetes of the young pregnancy.
    Taylor RAM; Mackie A; Mogra R; Pinner J; Rajendran S; Ross GP
    Diabet Med; 2019 Feb; 36(2):252-255. PubMed ID: 30362177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and spectrum of glucokinase mutations in an adult Maltese population.
    Pace NP; Grech CA; Vella B; Caruana R; Vassallo J
    Acta Diabetol; 2022 Mar; 59(3):339-348. PubMed ID: 34677673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic deletion of a short fragment of glucokinase in rabbit by CRISPR/Cas9 leading to hyperglycemia and other typical features seen in MODY-2.
    Song Y; Sui T; Zhang Y; Wang Y; Chen M; Deng J; Chai Z; Lai L; Li Z
    Cell Mol Life Sci; 2020 Aug; 77(16):3265-3277. PubMed ID: 31720743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparison of Daily Glucose Fluctuation Between GCK-MODY and Type 2 Diabetes Using Continuous Glucose Monitoring Technology.
    Ren Q; Zhang P; Pang W; Ma Y; Gong S; Ba T; Liu W; Zhang F; Zhang X; Zhang R; Wang X; Zhang X; Yang W; Lv F; Gao L; Han X; Ji L
    Diabetes; 2023 Jun; 72(6):812-818. PubMed ID: 36939643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucokinase mutations in pediatric patients with impaired fasting glucose.
    Aloi C; Salina A; Minuto N; Tallone R; Lugani F; Mascagni A; Mazza O; Cassanello M; Maghnie M; d'Annunzio G
    Acta Diabetol; 2017 Oct; 54(10):913-923. PubMed ID: 28726111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
    Hohendorff J; Szopa M; Skupien J; Kapusta M; Zapala B; Platek T; Mrozinska S; Parpan T; Glodzik W; Ludwig-Galezowska A; Kiec-Wilk B; Klupa T; Malecki MT
    Endocrine; 2017 Aug; 57(2):272-279. PubMed ID: 28593615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucokinase gene mutations: structural and genotype-phenotype analyses in MODY children from South Italy.
    Tinto N; Zagari A; Capuano M; De Simone A; Capobianco V; Daniele G; Giugliano M; Spadaro R; Franzese A; Sacchetti L
    PLoS One; 2008 Apr; 3(4):e1870. PubMed ID: 18382660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical implications of the glucokinase impaired function - GCK MODY today.
    Hulín J; Škopková M; Valkovičová T; Mikulajová S; Rosoľanková M; Papcun P; Gašperíková D; Staník J
    Physiol Res; 2020 Dec; 69(6):995-1011. PubMed ID: 33129248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia.
    Osbak KK; Colclough K; Saint-Martin C; Beer NL; Bellanné-Chantelot C; Ellard S; Gloyn AL
    Hum Mutat; 2009 Nov; 30(11):1512-26. PubMed ID: 19790256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. beta-cell genes and diabetes: quantitative and qualitative differences in the pathophysiology of hepatic nuclear factor-1alpha and glucokinase mutations.
    Pearson ER; Velho G; Clark P; Stride A; Shepherd M; Frayling TM; Bulman MP; Ellard S; Froguel P; Hattersley AT
    Diabetes; 2001 Feb; 50 Suppl 1():S101-7. PubMed ID: 11272165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies.
    Steele AM; Wensley KJ; Ellard S; Murphy R; Shepherd M; Colclough K; Hattersley AT; Shields BM
    PLoS One; 2013; 8(6):e65326. PubMed ID: 23799006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.